Clinical trial
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
NCT07001007 is registered in ClinicalTrials.gov with HJN Sverige AB/Neko Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
- Lead sponsor
- HJN Sverige AB/Neko Health
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 1, 2024
- Completion date
- June 30, 2026
- Enrollment
- 1,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve disease, arterial stiffness, coronary arterial disease (cad), heart failure